A recent survey shared in FiercePharma pointed to an upward trend in general public opinion of the pharmaceutical industry. But there is still work to be done.*
Rob Laurens, Principal, Human Resources and Quality Assurance, credits much of this momentum to the work of everyone in the clinical R&D sector.
The shift in the general public perception of clinical trials as a treatment option is reflected in BBK's day-to-day work. Sponsors and sites are adopting and embracing more patient-centric approaches within protocol design and supportive services. His overall message? Keep up the good work!
Share your opinion. Leave a comment below.